Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Astrogenetix, Inc.
Astrogenetix to Conduct MRSA Research on Shuttle Mission
March 25th, 2009
Astrogenetix, Inc., a subsidiary of the Astrotech Corporation (Nasdaq:SPAB), announced it is conducting novel pharmaceutical research aboard Shuttle Discovery (STS-119) on NASA mission 15A scheduled to launch this evening and destined for the International Space Station (ISS). Astrogenetix is conducting a microgravity-based virulence survey study with methicillin-resistant Staphylococcus aureus (MRSA), Listeria monocytogenes, Enterococcus faecalis and Candida albicans The research will utilize the unique environment of microgravity, which is known to impact virulence (infection potential) of microbes, to help discover potential targets for a vaccine or therapeutic agent to fight infections...
Source: Vaccine Weekly (2009-03-25)
|
